Indiana Attorney General Todd Rokita has joined a multistate legal action against the Trump administration, targeting the federal government's move to reclassify marijuana to a lower schedule under the Controlled Substances Act. The lawsuit, filed alongside attorneys general from at least two other states, argues that the rescheduling process was procedurally defective - not that marijuana should be treated more leniently. For an industry that has watched federal rescheduling as a potential lifeline on banking access, tax treatment, and interstate legitimacy, this legal challenge arrives at an uncomfortable moment.
What the Rescheduling Fight Is Actually About
Federal marijuana rescheduling - specifically, the proposed move from Schedule I to Schedule III under the Controlled Substances Act - matters to licensed cannabis businesses for reasons that go well beyond symbolism. Schedule I classification is the legal hook behind Section 280E of the Internal Revenue Code, which bars cannabis operators from deducting ordinary business expenses. Dispensaries, cultivators, and vertically integrated multi-state operators have been absorbing effective tax rates far higher than comparable retail businesses for years precisely because of that classification. A successful move to Schedule III would not automatically resolve 280E, but it would structurally undercut the argument that keeps the provision in place.
There is also the banking question. Financial institutions remain broadly reluctant to serve cannabis businesses - not solely because of federal scheduling, but scheduling is part of the risk calculus. The SAFE Banking Act has stalled repeatedly in Congress. Without federal rescheduling clearing some of that regulatory fog, most cannabis operators remain dependent on cash-heavy operations, armored transport, and workaround payment solutions that add cost and compliance complexity at every point in the supply chain.
To put it plainly: rescheduling is not a cure-all, but it is a foundational piece of the structural reform the industry has been waiting on. Any legal challenge that delays or invalidates that process sets the clock back.
The Procedural Argument - and Why It Has Weight
The attorneys general are not arguing that marijuana is safe or that federal policy should accommodate state-legal markets. Their claim is narrower: that the rescheduling process failed to follow proper administrative procedure. Here's the catch - procedural challenges to federal rulemaking are not frivolous. Administrative law has teeth. Courts have vacated significant federal agency actions on procedural grounds when notice-and-comment requirements, agency authority limits, or statutory mandates were not properly observed.
If the challenge succeeds - or even drags the rescheduling process into extended litigation - the practical effect on licensed cannabis businesses is a continuation of the status quo. That means 280E stays operative, banking access stays constrained, and the interstate commerce restrictions that prevent legal multistate supply chains from functioning like any other consumer goods distribution network remain intact.
What's striking here is the source of the challenge. A Republican attorney general in a state where all marijuana use remains illegal suing the Trump administration over a policy the administration itself set in motion is not the standard political alignment. It signals that opposition to federal cannabis reform is not a single-party issue in every state, and that the legal road for rescheduling - already long - may be longer than many in the industry assumed.
Indiana's Position and What It Means for Regional Market Development
Indiana remains one of the few states in the Midwest with no legal cannabis market - not adult-use, not medical. Legislative efforts to establish a medical cannabis program have been introduced but have not cleared the legislature. That context matters: Rokita's lawsuit is not a defensive action protecting an existing state-regulated market from federal interference. It is, in effect, a prohibition state's attorney general seeking to slow federal policy liberalization.
For operators in neighboring states - Illinois, Michigan, Ohio - Indiana represents a significant population corridor that feeds cross-border cannabis tourism. Dispensaries near Indiana's borders in Illinois and Michigan have long absorbed customer traffic from Indiana residents for whom no home-state purchase option exists. Whether Indiana eventually legalizes medical use will depend partly on how the federal regulatory picture settles. A prolonged legal fight over rescheduling does nothing to accelerate that.
For wholesale suppliers, brands, and technology vendors watching the Midwest market, Indiana's continued prohibition status - reinforced politically by actions like this lawsuit - means that regional expansion planning should treat Indiana as a long horizon. Compliance infrastructure, seed-to-sale tracking integrations, and POS deployments in new Indiana facilities are not near-term line items.
The Operational Risk for Licensed Operators Watching This Case
Licensed dispensary operators and their finance teams should watch this litigation carefully - not because the outcome is certain in either direction, but because the timeline matters. Rescheduling-dependent business decisions, including structural changes to how some operators account for cost of goods sold versus deductible expenses, should not be made in anticipation of a regulatory shift that is now under active legal challenge.
The same applies to payment processors and fintech companies that have been positioning for expanded cannabis market entry on the assumption that rescheduling would reduce their institutional risk exposure. That assumption now carries more uncertainty. Compliance officers at multi-state operators should flag this case in their regulatory watch logs and revisit any internal timelines tied to federal policy change.
The broader industry lesson here is one the cannabis sector keeps relearning: federal policy movement is rarely linear, and the opposition does not always come from the direction you expect.
